Autonomix Medical Announces Material Definitive Agreement

Ticker: AMIX · Form: 8-K · Filed: Jul 22, 2025 · CIK: 1617867

Sentiment: neutral

Topics: material-definitive-agreement, equity-securities, corporate-events

TL;DR

Autonomix Medical signed a big deal, sold some stock, and filed other important info.

AI Summary

Autonomix Medical, Inc. announced on July 21, 2025, that it entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and other events. The filing includes financial statements and exhibits.

Why It Matters

This filing indicates significant corporate activity, potentially involving new contracts or financing, which could impact the company's future operations and stock performance.

Risk Assessment

Risk Level: medium — The filing mentions unregistered sales of equity securities, which can sometimes dilute existing shareholders' value.

Key Players & Entities

FAQ

What is the nature of the material definitive agreement entered into by Autonomix Medical, Inc.?

The filing does not specify the details of the material definitive agreement, only that one was entered into on July 21, 2025.

When was the earliest event reported in this 8-K filing?

The earliest event reported was on July 21, 2025.

What is Autonomix Medical, Inc.'s state of incorporation?

Autonomix Medical, Inc. is incorporated in Delaware.

What is the SEC file number for Autonomix Medical, Inc.?

The SEC file number for Autonomix Medical, Inc. is 001-41940.

What are the principal executive offices of Autonomix Medical, Inc.?

The principal executive offices are located at 21 Waterway Avenue, Suite 300, The Woodlands, TX 77380.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 22, 2025 regarding Autonomix Medical, Inc. (AMIX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing